What does CUSIP 74275C205 represent in this 13F holders report?

CUSIP 74275C205 is the security identifier for PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW in Q3 2023?

20 institutional investors reported PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW for Q3 2023. Use the holders table for investor-level position and value details.

PROCESSA PHARMACEUTICALS INC - COM NEW (PCSA)

CUSIP: 74275C205

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COM NEW
Total 13F shares: 1,385,887
Total 13F value: $349,820
Share change: -3,633
SEC-reported price per share: $0.25
Number of holders: 20
Value change: -$16,008
Number of buys: 11
Number of sells: 7

Security key

74275C205

Report period

Q3 2023

Institutions

Top holders

PCSA full security history Ownership snapshot Full 13F holder table Processa Pharmaceuticals, Inc. SEC filings Processa Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Walleye Capital LLC

Disclosed value leader

Walleye Capital LLC

Comparable rows

0/15

Latest evidence

30 Jun 2023

13F 3/4/5 Highest disclosed value: $182,402 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Walleye Capital LLC has the largest disclosed position value at $182.4K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Walleye Capital LLC's linked filing trail.

Disclosed position value Top 5

Walleye Capital LLC $182.4K

VANGUARD GROUP INC $179.9K

CITADEL ADVISORS LLC $140.7K

Robert Michael Floyd $51.6K

Virgil Thompson $42.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Walleye Capital LLC	13F Company 13F	— denominator unverified	$182,402 366,637 shares	—	30 Jun 2023
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$179,935 361,679 shares	—	30 Jun 2023
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$140,711 282,837 shares	—	30 Jun 2023
Robert Michael Floyd	3/4/5 Chief Operating Officer 3/4/5	— denominator unverified	$51,618 172,061 shares	—	09 Feb 2023
Virgil Thompson	3/4/5 Director 3/4/5	— mixed-class rows	$42,163 241,907 shares mixed-class rows	—	27 Jun 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$34,241 68,827 shares	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,385,887

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %